Glenmark Pharma gets USFDA nod for diabetes management drug

"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by
the United States Food & Drug Administration (USFDA) for metformin
hydrochloride extended release tablets USP, 500 mg and 1000 mg, the
generic version of Glumetza extended release tablets, 500 mg and 1,000
mg, of Salix Pharmaceuticals Inc," the drug maker said in a filing to
BSE.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-diabetes-management-drug/articleshow/72235821.cms